98 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Vétoquinol to acquire the animal health business of Bioniche Life Sciences Inc. LURE, FRANCE and BELLEVILLE, ONTARIO, CANADA, February 27, 2014 - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche’s Animal Health business for the cash purchase price of CAD$61 million. |
27/02/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/02/2014 | Voting rights | |
Programme de rachat - janvier 2014 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
17/02/2014 | Monthly communication regarding buyback programs | |
7.8% organic growth in Q4 2013 The Vétoquinol Group posted Q4 2013 sales of €80.1 million, up +7.8% like for like from Q4 2012. |
23/01/2014 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - December 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/01/2014 | Voting rights | |
Programme de rachat - décembre 2013 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
17/01/2014 | Monthly communication regarding buyback programs | |
Bilan semestriel des moyens alloués au contrat de liquidité (2013) - french Au 31 décembre 2013 |
16/01/2014 | Liquidity contract | |
Jean-Yves RAVINET appointed Group Chief Operating Officer Lure (France), January 7, 2014 – The Vétoquinol Group announces the appointment of Jean-Yves Ravinet as Group Chief Operating Officer. |
07/01/2014 | Public releases |